The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and chronic kidney disease.

(HealthDay News) — Restaging magnetic resonance imaging (MRI) can predict organ preservation and survival with rectal cancer, according to a study published online in Radiology.

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in patients with MASH and liver fibrosis.

Although finerenone has kidney protective effects in patients with chronic kidney disease and type 2 diabetes, it does not appear to slow kidney function decline in patients with heart failure with ...

Investigators have identified a platelet count threshold that appears prognostic in patients with ESRD hospitalized in the ICU.

(HealthDay News) — In a clinical guideline issued by the American Heart Association and American Stroke Association and published online in Stroke, updated recommendations are presented for the ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams ...

(HealthDay News) — The fibrinogen-to-albumin ratio (FAR) is an independent risk factor for development of any preeclampsia (PE) and PE with severe features (sPE), according to a study presented at the ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.